Cas no 252662-37-6 (N-(5-formyl-1,3-thiazol-2-yl)acetamide)
N-(5-formyl-1,3-thiazol-2-yl)acetamide Chemical and Physical Properties
Names and Identifiers
-
- Acetamide, N-(5-formyl-2-thiazolyl)-
- N-(5-formyl-2-thiazolyl)Acetamide
- N-(5-ForMylthiazol-2-yl)acetaMide
- N-(5-formyl-1,3-thiazol-2-yl)acetamide
- AS-61479
- SCHEMBL4100380
- AKOS006313988
- CKA66237
- CS-0136562
- KZLHASJXPLGUOE-UHFFFAOYSA-N
- EN300-2971423
- 252662-37-6
- A927995
- DA-43037
- Z1198261425
- MFCD09909306
- SY269273
- N-(5-formyl-thiazol-2-yl)-acetamide
-
- MDL: MFCD09909306
- Inchi: 1S/C6H6N2O2S/c1-4(10)8-6-7-2-5(3-9)11-6/h2-3H,1H3,(H,7,8,10)
- InChI Key: KZLHASJXPLGUOE-UHFFFAOYSA-N
- SMILES: S1C(C=O)=CN=C1NC(C)=O
Computed Properties
- Exact Mass: 170.01499861g/mol
- Monoisotopic Mass: 170.01499861g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 11
- Rotatable Bond Count: 3
- Complexity: 174
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 87.3?2
N-(5-formyl-1,3-thiazol-2-yl)acetamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A059006789-250mg |
N-(5-formylthiazol-2-yl)acetamide |
252662-37-6 | 95% | 250mg |
$238.68 | 2023-09-02 | |
| Alichem | A059006789-1g |
N-(5-formylthiazol-2-yl)acetamide |
252662-37-6 | 95% | 1g |
$579.15 | 2023-09-02 | |
| eNovation Chemicals LLC | D764398-100mg |
N-(5-ForMylthiazol-2-yl)acetaMide |
252662-37-6 | 95% | 100mg |
$180 | 2024-06-06 | |
| eNovation Chemicals LLC | D764398-250mg |
N-(5-ForMylthiazol-2-yl)acetaMide |
252662-37-6 | 95% | 250mg |
$270 | 2024-06-06 | |
| eNovation Chemicals LLC | D764398-1g |
N-(5-ForMylthiazol-2-yl)acetaMide |
252662-37-6 | 95% | 1g |
$545 | 2024-06-06 | |
| Chemenu | CM515687-1g |
N-(5-Formylthiazol-2-yl)acetamide |
252662-37-6 | 95% | 1g |
$766 | 2024-07-28 | |
| abcr | AB542435-250 mg |
N-(5-Formylthiazol-2-yl)acetamide, 95%; . |
252662-37-6 | 95% | 250MG |
€643.30 | 2023-04-14 | |
| abcr | AB542435-1 g |
N-(5-Formylthiazol-2-yl)acetamide, 95%; . |
252662-37-6 | 95% | 1g |
€1,232.70 | 2023-04-14 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1207202-100mg |
N-(5-Formylthiazol-2-yl)acetamide |
252662-37-6 | 98% | 100mg |
¥1456 | 2023-04-14 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1207202-250mg |
N-(5-Formylthiazol-2-yl)acetamide |
252662-37-6 | 98% | 250mg |
¥2496 | 2023-04-14 |
N-(5-formyl-1,3-thiazol-2-yl)acetamide Related Literature
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
-
M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
-
Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
Additional information on N-(5-formyl-1,3-thiazol-2-yl)acetamide
Professional Introduction to N-(5-formyl-1,3-thiazol-2-yl)acetamide (CAS No. 252662-37-6)
N-(5-formyl-1,3-thiazol-2-yl)acetamide is a significant compound in the field of chemical and pharmaceutical research, characterized by its unique structural and functional properties. This compound, identified by the CAS number 252662-37-6, has garnered considerable attention due to its potential applications in medicinal chemistry and drug development. The molecular structure of N-(5-formyl-1,3-thiazol-2-yl)acetamide consists of a thiazole ring substituted with a formyl group and an acetamide moiety, which contributes to its reactivity and versatility in synthetic chemistry.
The thiazole core is a heterocyclic aromatic compound that is widely recognized for its presence in numerous biologically active molecules. Thiazole derivatives have been extensively studied for their antimicrobial, anti-inflammatory, and anticancer properties. In particular, the formyl group attached to the thiazole ring in N-(5-formyl-1,3-thiazol-2-yl)acetamide enhances its reactivity, making it a valuable intermediate in the synthesis of more complex molecules. The acetamide group provides a polar functional handle that can be further modified through various chemical reactions, such as condensation or hydrolysis, to yield a wide range of pharmacologically relevant compounds.
Recent advancements in the field of medicinal chemistry have highlighted the importance of N-(5-formyl-1,3-thiazol-2-yl)acetamide in the development of novel therapeutic agents. Researchers have been exploring its potential as a precursor in the synthesis of small-molecule inhibitors targeting specific biological pathways. For instance, studies have demonstrated its utility in generating derivatives that interact with enzymes involved in cancer cell proliferation and apoptosis. The formyl group on the thiazole ring can undergo condensation reactions with amino acids or other nucleophiles to form Schiff bases or imines, which are known to exhibit significant biological activity.
Moreover, the structural features of N-(5-formyl-1,3-thiazol-2-yl)acetamide make it an attractive candidate for further derivatization using modern synthetic techniques. Transition metal-catalyzed reactions, such as cross-coupling reactions, have been employed to introduce additional functional groups or to connect this compound with other molecular fragments. These methods allow for the creation of highly customized derivatives with tailored biological properties. Such flexibility is crucial in drug discovery pipelines, where the ability to modify molecular structures is essential for optimizing potency and selectivity.
In clinical research, N-(5-formyl-1,3-thiazol-2-yl)acetamide has been investigated for its potential therapeutic effects in various diseases. Preclinical studies have shown promising results in models of inflammation and neurodegeneration. The compound’s ability to modulate inflammatory pathways has led to interest in its use as an anti-inflammatory agent. Additionally, its interaction with biological targets suggests possible applications in treating neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. These findings underscore the importance of continued research into this compound and its derivatives.
The synthesis of N-(5-formyl-1,3-thiazol-2-yl)acetamide involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been developed to improve yield and purity, ensuring that researchers can obtain high-quality material for their studies. Techniques such as high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy are commonly used to characterize the compound and confirm its structural integrity. These analytical methods are critical for ensuring that the final product meets the stringent requirements of pharmaceutical applications.
The role of computational chemistry in understanding the behavior of N-(5-formyl-1,3-thiazol-2-yl)acetamide cannot be overstated. Molecular modeling studies have provided insights into how this compound interacts with biological targets at the atomic level. By simulating these interactions using computer algorithms, researchers can predict binding affinities and identify potential lead compounds for further optimization. This approach has significantly accelerated the drug discovery process by allowing virtual screening of large libraries of compounds before experimental testing.
The future prospects for N-(5-formyl-1,3-thiazol-2-yl)acetamide are promising, with ongoing research aimed at expanding its applications in medicine and biotechnology. Innovations in synthetic chemistry and drug delivery systems may further enhance its utility as a therapeutic agent. Collaborative efforts between academic institutions and pharmaceutical companies are essential for translating laboratory findings into clinical treatments that benefit patients worldwide. As our understanding of biological systems continues to grow, compounds like N-(5-formyl-1,3-thiazol-2-yl)acetamide will play an increasingly important role in addressing complex diseases.
252662-37-6 (N-(5-formyl-1,3-thiazol-2-yl)acetamide) Related Products
- 61996-32-5(2-Acetamido-5-methylthiazole)
- 92940-24-4(2-(diethylamino)-1,3-thiazole-5-carbaldehyde)
- 1314950-78-1(N-(5-(Hydroxymethyl)thiazol-2-yl)acetamide)
- 320423-50-5(2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde)
- 172481-15-1(5-Thiazolecarboxylicacid, 2-[(2-hydroxyacetyl)amino]-)
- 172481-16-2( )
- 1170060-19-1(2-Acetamido-1,3-thiazole-5-carboxylic Acid)
- 575497-12-0(2-chloro-N-(5-methyl-1,3-thiazol-2-yl)acetamide)
- 1005-28-3(2-(dimethylamino)-1,3-thiazole-5-carbaldehyde)
- 99903-61-4(N-(5-cyano-1,3-thiazol-2-yl)acetamide)